3era Parada | Sociedad Argentina de Gastroenterología
PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence
Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records | Upsala Journal of Medical Sciences
Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Ulcerative Colitis and Pregnancy | IntechOpen
Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
Megacolon tossico e colite pseudomembranosa Megacolon tossico e colite pseudomembranosa
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1. - Document - Gale OneFile:
Mucosal gene expression in inflammatory bowel disease | CEG
Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study - Frontiers
Advances in Clinical and Experimental Medicine
Frontiers | Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Full article: New treatment strategies for ulcerative colitis
![PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,](https://og.oa.mg/Infliximab%20is%20more%20effective%20than%20cyclosporine%20as%20a%20rescue%20therapy%20for%20acute%20severe%20ulcerative%20colitis:%20a%20retrospective%20single-center%20study.png?author=%20Marco%20Le%20Grazie,%20Siro%20Bagnoli,%20Gabriele%20Dragoni,%20Saverio%20Caini,%20Vito%20Annese,%20Tommaso%20Innocenti,%20Simona%20Deiana,%20Natalia%20Manetti,%20Stefano%20Milani,%20Andrea%20Galli,%20Monica%20Milla "PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,")
PDF] Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study by Marco Le Grazie, Siro Bagnoli, Gabriele Dragoni, Saverio Caini, Vito Annese,
Frontiers | Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
Frontiers | Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Steroid Resistance/Dependence Might Be an Alarming Feature for Cytomegalovirus Infection Among Ulcerative Colitis Patients With
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine
Low adherence to treatment is a weak link in the problems of ulcerative colitis - Parfenov - Terapevticheskii arkhiv
